Novartis Stock

Novartis Debt 2024

Novartis Debt

12,955 USD

Ticker

NOVN.SW

ISIN

CH0012005267

WKN

904278

In 2024, Novartis's total debt was 12,955 USD, a -36.47% change from the 20,392 USD total debt recorded in the previous year.

Novartis Aktienanalyse

What does Novartis do?

Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Novartis's Debt Structure

Novartis's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Novartis's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Novartis’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Novartis’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Novartis stock

What is the debt of Novartis this year?

Novartis has a debt level of 12,955 USD this year.

What was the debt of Novartis compared to the previous year?

The debt of Novartis has increased by -36.47% compared to the previous year dropped.

What are the consequences of high debt for investors in Novartis?

High debt can pose a risk for investors of Novartis, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Novartis?

Low debt means that Novartis has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Novartis affect the company?

An increase in debt of Novartis can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Novartis affect the company?

A reduction in debt of Novartis can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Novartis?

Some factors that can influence the debt of Novartis include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Novartis so important for investors?

The debts of Novartis are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Novartis take to change the debt?

To change the debt, Novartis can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Novartis pay?

Over the past 12 months, Novartis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Novartis is expected to pay a dividend of 3.28 USD.

What is the dividend yield of Novartis?

The current dividend yield of Novartis is .

When does Novartis pay dividends?

Novartis pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Novartis?

Novartis paid dividends every year for the past 26 years.

What is the dividend of Novartis?

For the upcoming 12 months, dividends amounting to 3.28 USD are expected. This corresponds to a dividend yield of 2.98 %.

In which sector is Novartis located?

Novartis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novartis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novartis from 3/11/2024 amounting to 3.3 USD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Novartis pay the last dividend?

The last dividend was paid out on 3/11/2024.

What was the dividend of Novartis in the year 2023?

In the year 2023, Novartis distributed 3.1 USD as dividends.

In which currency does Novartis pay out the dividend?

The dividends of Novartis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Novartis stock can be added to a savings plan with the following providers: ING

Andere Kennzahlen von Novartis

Our stock analysis for Novartis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.